Start:
April 24, 2018
End:
January 2020
Enrollment:
75
This study aims to better understand the relationship between variations of the APOE gene and metabolism by testing metabolic rate at rest and during a cognitive challenge in healthy adults. Results may help investigators identify new targets for the prevention and treatment of cognitive decline and dementia.
Minimum Age: 18 Years
Maximum Age: 65 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: Lance Johnson
Source: ClinicalTrials.gov ID: NCT03109561
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health